At higher doses, some concern exists about pro-inflammatory effects: LL-37 can activate NF-kB pathways, potentially worsening certain inflammatory conditions
Research-grade peptides are not manufactured under the same quality standards as pharmaceutical-grade compounds and are not intended for human use
Lyophilized (powder) form should be stored at -20C for long-term stability
All treatment plans are customized to minimize adverse events, potential side effects, and common side effects such as nausea, nasal congestion, joint pain, blurred vision, or transient blood pressure changes
Baer et al (97) demonstrated that liraglutide, a GLP-1RA, could mitigate sepsis-induced acute lung injury by reducing various inflammatory markers in the lungs, including the number of immune cells and the concentration of pro-inflammatory factors